Avanos Medical (AVNS) Total Non-Current Liabilities (2013 - 2026)
Avanos Medical recorded quarterly Total Non-Current Liabilities of $253.9 million in Q1 2026, down 9.96% quarter-over-quarter from $282.0 million in Q4 2025, and down 3.79% year-over-year from $263.9 million in Q1 2025.
Avanos Medical's Total Non-Current Liabilities history runs 14 years deep, the most recent figure standing at $253.9 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities fell 3.79% year-over-year to $253.9 million; the TTM figure through Mar 2026 stood at $253.9 million (down 3.79% YoY), while the FY2025 annual figure was $282.0 million, down 12.23% from the prior year.
- Total Non-Current Liabilities came in at $253.9 million for Q1 2026 at Avanos Medical, down from $282.0 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $487.2 million in Q3 2023 to a low of $253.9 million in Q1 2026.
- A 5-year average of $388.1 million and a median of $420.7 million in 2023 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities surged 48.48% in 2022 and slumped 39.24% in 2025, its largest moves.
- Avanos Medical's Total Non-Current Liabilities stood at $475.2 million in 2022, then dropped by 6.12% to $446.1 million in 2023, then fell by 27.98% to $321.3 million in 2024, then slipped by 12.23% to $282.0 million in 2025, then dropped by 9.96% to $253.9 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $253.9 million, $282.0 million, and $269.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 253.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 253.90 Mn |
| Dec 31, 2025 | 282.00 Mn |
| Sep 30, 2025 | 269.00 Mn |
| Jun 30, 2025 | 258.40 Mn |
| Mar 31, 2025 | 263.90 Mn |
| Dec 31, 2024 | 321.30 Mn |
| Sep 30, 2024 | 415.90 Mn |
| Jun 30, 2024 | 425.30 Mn |
| Mar 31, 2024 | 422.60 Mn |
| Dec 31, 2023 | 446.10 Mn |
| Sep 30, 2023 | 487.20 Mn |
| Jun 30, 2023 | 416.50 Mn |
| Mar 31, 2023 | 420.70 Mn |
| Dec 31, 2022 | 475.20 Mn |
| Sep 30, 2022 | 483.90 Mn |
| Jun 30, 2022 | 473.50 Mn |
| Mar 31, 2022 | 482.00 Mn |
| Dec 31, 2021 | 323.90 Mn |
| Sep 30, 2021 | 325.90 Mn |
| Jun 30, 2021 | 376.40 Mn |
| Mar 31, 2021 | 385.30 Mn |
| Dec 31, 2020 | 405.30 Mn |
| Sep 30, 2020 | 497.80 Mn |
| Jun 30, 2020 | 483.30 Mn |
| Mar 31, 2020 | 496.40 Mn |
| Dec 31, 2019 | 523.20 Mn |
| Sep 30, 2019 | 529.00 Mn |
| Jun 30, 2019 | 500.90 Mn |
| Mar 31, 2019 | 548.40 Mn |
| Dec 31, 2018 | 516.40 Mn |
| Sep 30, 2018 | 534.90 Mn |
| Jun 30, 2018 | 601.20 Mn |
| Mar 31, 2018 | 920.90 Mn |
| Dec 31, 2017 | 948.70 Mn |
| Sep 30, 2017 | 936.30 Mn |
| Jun 30, 2017 | 938.10 Mn |
| Mar 31, 2017 | 925.60 Mn |
| Dec 31, 2016 | 945.50 Mn |
| Sep 30, 2016 | 93.40 Mn |
| Jun 30, 2016 | 93.60 Mn |
| Mar 31, 2016 | 52.10 Mn |
| Dec 31, 2015 | 51.60 Mn |
| Sep 30, 2015 | 52.60 Mn |
| Jun 30, 2015 | 53.90 Mn |
| Mar 31, 2015 | 52.20 Mn |
| Dec 31, 2014 | 48.10 Mn |
| Sep 30, 2014 | 92.50 Mn |
| Dec 31, 2013 | 94.50 Mn |